Prothena announced that its partner Novo Nordisk has paid the company a $50 million clinical milestone payment.
Show original
The triggering of this payment is related to the progress of the Phase III clinical trial of Coramitug (formerly codenamed Prx004) for the treatment of transthyretin amyloid cardiomyopathy. Currently, this pivotal clinical trial is ongoing.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!
You may also like
Trending news
MoreHewlett Packard Enterprise's Chief Financial Officer stated that the company's performance guidance is the most accurate estimate based on currently available information.
The CEO of HPE stated during a conference call that the current upward trend in component and memory prices is expected to continue until 2027.
Crypto prices
More
Bitcoin
BTC
$68,876.88
+2.85%
Ethereum
ETH
$2,027.15
+3.79%
Tether USDt
USDT
$1
+0.03%
BNB
BNB
$639.38
+3.58%
XRP
XRP
$1.37
+1.93%
USDC
USDC
$1
+0.01%
Solana
SOL
$85.96
+4.81%
TRON
TRX
$0.2860
-1.58%
Dogecoin
DOGE
$0.09138
+2.19%
Cardano
ADA
$0.2586
+2.68%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now